-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Men 2010: 12th International…
16–18 September, 2010
This two-day meeting will provide a forum for educating basic and clinical…
-
Ribonuclease H2010
20–22 September, 2010
We expect to bring together scientists interested in making as much…
-
Third Annual Ultra Orphan…
27–29 September, 2010
Centric Health Resources Presents Third Annual Ultra Orphan Conference…
-
Brain, Blood and Iron: Joint…
1–2 October, 2010
The overall objectives of this workshop are to (1) define NA and NBIA…
Events
-
Discovered Gene Causes Kabuki Syndrome
Monday, August 16, 2010
Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardationInstead of sequencing the entire human genome, the new approach seq
-
Merlin Protein Found to Control Liver Stem Cells, Prevent Tumor Development
Friday, August 13, 2010
A protein known to be involved in a rare hereditary cancer syndrome may have a role in the regulation of liver stem cells and the development of liver cancerIn the August 15 issue of Genes & Development, a Massachusetts General Hospital (MGH) research team describes finding that the protein ca
-
The Cancer Biomarker Conundrum: Too Many False Discoveries
Friday, August 13, 2010
The boom in cancer biomarker investments over the past 25 years has not translated into major clinical successThe reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article published online August 12 in The Jou
-
Medical Researchers at U of Alberta Discover Potential Treatment for Pulmonary Hypertension
Thursday, August 12, 2010
Researchers in the Faculty of Medicine & Dentistry at the University of Alberta are one step closer to a treatment for a deadly diseasePulmonary arterial hypertension, which is high blood pressure in the lungs, currently has only a few treatment options but most cases lead to premature death.
-
Neurochip Technology Developed by Canadian Team
Thursday, August 12, 2010
The University of Calgary, Faculty of Medicine scientists who proved it is possible to cultivate a network of brain cells that reconnect on a silicon chip – or the brain on a microchip – have been involved in the development of new technology that monitors brain cell activity at a Deve
-
Spinal Muscular Atrophy May Also Affect the Heart
Thursday, August 12, 2010
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMAThese are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report
-
Deathstalker Scorpion Venom Could Improve Gene Therapy for Brain Cancer
Thursday, August 12, 2010
An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reportingThe substance allows therapeutic genes — genes that treat disease — to reach more brain cancer cells than current approaches, accord
-
Research Links Huntingtin to Neurogenesis
Thursday, August 12, 2010
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesisThe research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications f
-
Seeing Melanoma
Thursday, August 12, 2010
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percentThe five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence
-
Rosalind Franklin University Research Shows Promise for Treatment of a Fatal Childhood Disease
Wednesday, August 11, 2010
NORTH CHICAGO, IL – Michelle Hastings, PhD, Assistant Professor in the Department of Cell Biology and Anatomy, in the Chicago Medical School of Rosalind Franklin University of Medicine and Science, has been awarded a five-year $1.68 million grant from the National Institutes of Health to Dr.
